Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis
Authors
Keywords
-
Journal
BRAIN
Volume 136, Issue 4, Pages 1067-1082
Publisher
Oxford University Press (OUP)
Online
2013-03-22
DOI
10.1093/brain/awt041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neurofilament a biomarker of neurodegeneration in autoimmune encephalomyelitis
- (2012) Sharmilee Gnanapavan et al. AUTOIMMUNITY
- Antioxidant and bioenergetic coupling between neurons and astrocytes
- (2012) Seila Fernandez-Fernandez et al. BIOCHEMICAL JOURNAL
- Microglial neurotransmitter receptors trigger superoxide production in microglia; consequences for microglial-neuronal interactions
- (2012) Emma L. Mead et al. JOURNAL OF NEUROCHEMISTRY
- Newly lesioned tissue in multiple sclerosis--a role for oxidative damage?
- (2011) K. J. Smith BRAIN
- Oxidative damage in multiple sclerosis lesions
- (2011) L. Haider et al. BRAIN
- The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE)
- (2011) Travis Musgrave et al. BRAIN BEHAVIOR AND IMMUNITY
- Sodium channels and microglial function
- (2011) Joel A. Black et al. EXPERIMENTAL NEUROLOGY
- Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination
- (2010) Rakhi Sharma et al. ACTA NEUROPATHOLOGICA
- Safinamide in the treatment of Parkinson's disease
- (2010) Anthony HV Schapira EXPERT OPINION ON PHARMACOTHERAPY
- The Anticonvulsive Drug Lamotrigine Blocks Neuronal 4 2 Nicotinic Acetylcholine Receptors
- (2010) C. Zheng et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
- (2010) Raju Kapoor et al. LANCET NEUROLOGY
- Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis
- (2010) Emma C Tallantyre et al. Multiple Sclerosis Journal
- Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
- (2010) Ranjan Dutta et al. PROGRESS IN NEUROBIOLOGY
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
- Scavenger receptor control of chromogranin A-induced microglial stress and neurotoxic cascades
- (2009) Claudie Hooper et al. FEBS LETTERS
- Sodium channel activity modulates multiple functions in microglia
- (2009) Joel A. Black et al. GLIA
- NaV1.5 sodium channels in a human microglial cell line
- (2009) E. Nicholson et al. JOURNAL OF NEUROIMMUNOLOGY
- Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
- (2009) Bruce D Trapp et al. LANCET NEUROLOGY
- An expert opinion on safinamide in Parkinson's disease
- (2008) Marco Onofrj et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started